[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hip-pain-chronic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hip-pain-chronic":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,42,72,94,124,154,180],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100618154","peng-block-variants-with-dexamethasone-and-dexmedetomidine-in-older-adults-100618154",false,"NCT07327931","PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults","Comparison of Three Variants of PENG Block Using 20 mL of 0.2% Ropivacaine With Different Combinations of Dexamethasone and Perineural Dexmedetomidine in Patients Aged 65 Years and Older Undergoing Hip Surgery: A Randomized Controlled Trial.","Inclusion Criteria:\n\n* Age 65 years or older\n* Scheduled for elective or emergency hip surgery (e.g., hip fracture fixation or hip arthroplasty)\n* ASA physical status I-III\n* Ability to communicate pain intensity using the NRS scale\n* Written informed consent obtained from the patient or legal representative\n* Planned use of PENG block as part of multimodal perioperative analgesia\n\nExclusion Criteria:\n\n* Patient refusal or inability to provide informed consent\n* Allergy, intolerance, or contraindication to any study medication: ropivacaine, dexamethasone, dexmedetomidine\n* Pre-existing neurological deficit or neuropathy of the affected limb\n* Coagulopathy (INR \\>1.5, platelets \\\u003C100,000\u002FµL) or current therapeutic anticoagulation that contraindicates regional anesthesia\n* Infection at or near the injection site\n* Severe hepatic or renal impairment\n* History of chronic opioid use (daily opioids \\>30 days before surgery)\n* Cognitive impairment or delirium precluding reliable pain assessment\n* BMI \\> 40 kg\u002Fm² (if you want to exclude for technical difficulty)\n* Patients receiving another regional nerve block for hip surgery\n* Pregnancy or breastfeeding\n* Participation in another interventional clinical trial within 30 days","ALL","65 Years","100 Years",{"count":20,"type":21},120,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study will compare three different versions of the Pericapsular Nerve Group (PENG) block in adults aged 65 years and older who are undergoing surgery for hip conditions. The PENG block is a regional anesthesia technique that can reduce pain after surgery and decrease the need for strong opioid pain medications.\n\nAll patients in the study will receive the PENG block with 20 mL of 0.2% ropivacaine, but they will be divided into three groups based on the additional medications used:\n\nGroup 1: PENG block with ropivacaine plus 4 mg of dexamethasone given intravenously.\n\nGroup 2: PENG block with ropivacaine plus 25 micrograms of dexmedetomidine given near the nerves and 4 mg of dexamethasone given intravenously.\n\nGroup 3: PENG block with ropivacaine plus 25 micrograms of dexmedetomidine and 4 mg of dexamethasone given near the nerves.\n\nBoth dexmedetomidine and dexamethasone are medications that may improve the strength and duration of nerve blocks.\n\nThe main goal of this study is to determine which combination provides the best pain control after hip surgery, reduces the need for opioid medications, and improves patient comfort and recovery. We also aim to evaluate the safety and side-effects of each technique.\n\nWe hypothesize that adding both dexmedetomidine and dexamethasone near the nerves will provide the longest and most effective pain relief when compared to intravenous administration alone.\n\nThis trial may help identify the most effective PENG block formula for older adults undergoing hip surgery and could improve pain management, decrease complications related to opioids, and support faster recovery.",[27,28],"Hip Osteoarthritis","Hip Pain Chronic","RECRUITING","2026-05-20",{"date":32,"type":33},"2026-05-22","ACTUAL",{"date":35,"type":33},"2026-02-13",{"date":37,"type":21},"2027-01-31",{"name":39,"class":40},"Poznan University of Medical Sciences","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":41},"100640994","hips-feasibility-randomized-controlled-trial-100640994","NCT07586397","HIPS Feasibility Randomized Controlled Trial","HIPS Feasibility RCT Testing a Mind-Body Intervention to Improve Recovery for Individuals With Chronic Hip Pain","HIPS-RCT","Inclusion Criteria:\n\n1. Presenting with chronic (lasting ≥3 months) hip joint-related pain\n2. Fluent in English\n3. Age ≥18yr \\[If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence \\[KL\\] grade 0-1)\\]\n4. Score ≥3 for current hip pain on the Pain-VAS\n5. Psychological risk factor for the maintenance of pain by meeting ≥1 of the criteria listed below:\n\n   1. Score ≥ 20 on the PCS\n   2. Score ≤ 40 on the PSEQ\n   3. Score ≥ 17 on the TSK-11\n6. Exhibits sedentariness or dissatisfaction with physical activity by meeting ≥1 of the criteria listed below:\n\n   1. Physically active \\\u003C 150mins\u002Fweek according to the IPAQ-SF\n   2. Hip pain interferes with the ability to be physically active\n   3. Dissatisfaction with the current physical activity level\n\nExclusion Criteria:\n\n1. Previous surgery on the symptomatic (painful) hip\n2. Current pain referred from the lower back","18 Years",{"count":52,"type":21},50,[24],"The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.",[28,56,57],"Hip Pain","Physical Medicine and Rehabilitation",[59,60,61],"Intervention feasibility","Randomized controlled trial","Behavioral intervention development","NOT_YET_RECRUITING","2026-05-13",{"date":65,"type":33},"2026-05-15",{"date":67,"type":21},"2026-06-01",{"date":69,"type":21},"2028-06-01",{"name":71,"class":40},"Massachusetts General Hospital",{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":79,"targetDuration":4,"studyType":22,"phases":81,"briefSummary":83,"conditions":84,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":41},"100606855","phase-4-peng-vs-l-espb-with-s-espb-for-analgesia-in-total-hip-arthroplasty-100606855","NCT07180979","PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty","Comparison of Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block (L-ESPB) Combined With Sacral ESPB (S-ESPB) for Analgesia in Total Hip Arthroplasty (THA): A Randomized Clinical Trial","Inclusion Criteria:\n\n* Age ≥ 65 years\n* ASA physical status I-III\n* Elective unilateral THA via posterior or lateral approach\n* Informed consent provided\n\nExclusion Criteria:\n\n* Allergy to study drugs (ropivacaine, dexamethasone)\n* Chronic opioid use (\\>30 MME\u002Fday)\n* Coagulopathy or infection at the injection site\n* BMI \\> 40 kg\u002Fm²\n* Pre-existing motor weakness or neuropathy in the affected limb\n* Cognitive impairment precluding informed consent",{"count":80,"type":21},90,[82],"PHASE4","The goal of this clinical trial is to evaluate whether different types of regional anesthesia can improve pain control and functional recovery after total hip arthroplasty in adult patients undergoing elective hip replacement surgery.\n\nThe main questions it aims to answer are:\n\nDoes the PENG block reduce opioid use in the first 48 hours after surgery more effectively than the combined L-ESPB + S-ESPB technique? Which method provides better pain relief, preserves muscle strength, and supports earlier mobilization? Researchers will compare the Pericapsular Nerve Group (PENG) block with the combination of Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB + S-ESPB) to see which provides better pain control, fewer side effects, and faster recovery.\n\nParticipants will:\n\nBe randomly assigned to receive one of the two types of ultrasound-guided regional anesthesia Undergo standard hip replacement surgery under spinal anesthesia Be monitored for pain scores, opioid use, time to first walking, muscle strength, satisfaction, and side effects over the first 48 hours after surgery.",[27,85,28],"Hip Arthropathy","2026-05-06",{"date":88,"type":33},"2026-05-07",{"date":90,"type":33},"2025-09-15",{"date":92,"type":21},"2026-11-30",{"name":39,"class":40},{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":98,"acronym":4,"eligibilityCriteria":99,"healthyVolunteers":11,"sex":16,"minAge":100,"maxAge":101,"enrollmentInfo":102,"targetDuration":4,"studyType":22,"phases":104,"briefSummary":105,"conditions":106,"keywords":110,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":41},"100365525","psychosocial-interventions-for-young-adults-with-hip-pain-100365525","NCT04039386","Psychosocial Interventions for Young Adults With Hip Pain","Inclusion Criteria:\n\n* We will enroll young adults (15-39) presenting to one of several physical therapy and orthopedic practices in the state of Iowa for treatment of nonarthritic hip pain.\n* Chief complaint of hip pain or dysfunction, and a diagnosis of a nonarthritic hip condition including labral tear, femoroacetabular impingement (FAI), snapping hip, femoral anteversion or dysplasia.\n\nExclusion Criteria:\n\n* Exclusion criteria will include age \\\u003C15 or \\>40 years\n* Difficulty with written English\n* Treatment for alternative conditions such as trochanteric bursitis, hip dislocation, avascular necrosis or fracture.","15 Years","39 Years",{"count":103,"type":21},150,[24],"Psychosocial conditions are common in young adults with hip pain including depression, anxiety, pain catastrophizing, and narcotic use. The incidence of these conditions is not well defined. Interventions to optimize psychosocial conditions with non-surgical or surgical treatments has not been investigated. The goal of this project is to determine the incidence of psychosocial conditions in the young adult population with hip pain and determine if cognitive based therapy can improve clinical outcomes in these individuals.",[107,28,27,108,109],"Hip Dysplasia","Hip Arthritis","Psychosocial Problem",[56,111,112,113,114],"Hip Instability","Hip Impingement","Cognitive Based Therapy","Psychosocial Conditions","2026-04-14",{"date":117,"type":33},"2026-04-15",{"date":119,"type":21},"2026-09-01",{"date":121,"type":21},"2028-08-01",{"name":123,"class":40},"Michael C Willey",{"id":125,"slug":126,"hasResults":11,"nctId":127,"briefTitle":128,"officialTitle":129,"acronym":130,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":132,"enrollmentInfo":133,"targetDuration":4,"studyType":22,"phases":135,"briefSummary":136,"conditions":137,"keywords":140,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":41},"100504846","education-and-exercise-for-patients-with-longstanding-hip-and-groin-pain-100504846","NCT05853640","Education and Exercise for Patients With Longstanding Hip and Groin Pain","Patients With Longstanding HIP and Groin Pain Referred to Orthopedic Care: Effectiveness of Education and exerciSe ThERapy (HIPSTER)","HIPSTER","Inclusion Criteria:\n\n* Men and women aged 18-55 years\n* Referred to the Dept of Orthopedics due to hip and\u002For groin pain\n* Activity-related unilateral or bilateral groin pain \\>3 months\n* Pain reproduced with the FADIR test.\n\nExclusion Criteria:\n\n* Groin pain originating from any diagnosis with other treatment pathways, i.e., i) Acute traumatic hip injuries (such as hip dislocation, hip fractures); ii) Verified moderate or severe OA (Tönnis grade \\>1); iii) Palpable hernia; iv) Low-back pain with a positive straight leg raise test and\u002For hip and groin pain provoked primarily by repeated motions of the lumbar spine; v) Sacroiliac joint pain with thigh thrust test.\n* Co-morbidities potentially interfering with treatment, i.e., i) Co-morbidities overriding the hip and groin-related symptoms and dysfunction (such as other acute lower limb injuries, rheumatoid arthritis etc), ii) Co-morbidities prohibiting physical activity and training (heart disease etc), iii) Current psycho-social disorders requiring treatment.\n* Other: i) History of drug abuse within the last year; ii) Not understanding the language of interest (Scandinavian languages, or English).","55 Years",{"count":134,"type":21},122,[24],"Longstanding hip and groin pain (LHGP) is a common and debilitating problem in young to middle aged individuals. These patients often get referred to orthopedic departments. Consensus statements on the management of these patients commonly recommend a physical therapist-led intervention as the first line intervention. However, the optimal content and delivery of this intervention is currently unknown. In this study we will compare the effectiveness of usual care (unstructured physical therapist-led intervention) to a semi-structured, progressive individualized physical therapist-led intervention on hip-related quality of life in people with longstanding hip and groin pain referred to an orthopedic department.",[28,138,139],"Femoro Acetabular Impingement","Groin Injury",[141,142,143,144],"Hip-related pain","Longstanding hip and groin pain","Exercise therapy","Rehabilitation","2026-03-26",{"date":147,"type":33},"2026-04-02",{"date":149,"type":33},"2023-07-24",{"date":151,"type":21},"2030-12",{"name":153,"class":40},"Lund University",{"id":155,"slug":156,"hasResults":11,"nctId":157,"briefTitle":158,"officialTitle":159,"acronym":4,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":161,"targetDuration":4,"studyType":163,"phases":4,"briefSummary":164,"conditions":165,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":169,"lastUpdatePostDateStruct":170,"startDateStruct":172,"completionDateStruct":174,"leadSponsor":176,"locationsCount":179},"100364703","mdr---pmcf-study-for-taperloc-complete-stems-100364703","NCT04028687","MDR - PMCF Study for Taperloc Complete Stems","Post Market Clinical Follow up Study to Provide Safety, Performance and Clinical Benefits Data of the Taperloc Complete Stems","Inclusion Criteria:\n\n* Patient must be 18 years of age or older and skeletally mature\n* Patient must be willing and able to sign IRB approved informed consent\n* Patient must have undergone primary or revision hip arthroplasty with the -Taperloc Complete stem according to a cleared indication, which includes the following:\n* Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis\n* Rheumatoid arthritis\n* Correction of functional deformity\n* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques\n\nExclusion Criteria:\n\n* Off-label use\n* Infection\n* Sepsis\n* Osteomyelitis\n* Uncooperative patient or patient with neurologic disorders who are incapable of following directions\n* Osteoporosis\n* Metabolic disorders which may impair bone formation\n* Osteomalacia\n* Distant foci of infections which may spread to the implant site\n* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram\n* Vascular insufficiency, muscular atrophy, or neuromuscular disease\n* Patient is known to be pregnant or nursing\n* Patient is a prisoner\n* Patient is a known alcohol or drug abuser\n* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent",{"count":162,"type":21},820,"OBSERVATIONAL","The objective of this consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Taperloc Complete stems when used for primary or revision total hip arthroplasty (implants) at 1,3,5,7 and 10-year follow-up\\*. Since Taperloc Complete was introduced to the EU in 2010, all available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.",[108,166,167,168,28],"Hip Disease","Hip Fractures","Hip Injuries","2025-03-10",{"date":171,"type":33},"2025-03-11",{"date":173,"type":33},"2020-02-13",{"date":175,"type":21},"2032-02-12",{"name":177,"class":178},"Zimmer Biomet","INDUSTRY",3,{"id":181,"slug":182,"hasResults":11,"nctId":183,"briefTitle":184,"officialTitle":185,"acronym":4,"eligibilityCriteria":186,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":187,"targetDuration":4,"studyType":22,"phases":189,"briefSummary":190,"conditions":191,"keywords":192,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":41},"100533122","continuous-radiofrequency-in-hip-osteoarthritis-pain-a-randomized-clinical-trial-100533122","NCT06221709","Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.","Continuous Radiofrequency in Hip Osteoarthritis Pain: A Protocol of a Randomized Clinical Trial","Inclusion Criteria:\n\n* Individuals ≥ 18 years of age, with symptomatic unilateral hip osteoarthritis, grades II and III according to the Kellgreen and Lawrance classification, hip pain for more than six months (medial, anterior, anterolateral, and\u002For lateral region) will be included.\n\nExclusion Criteria:\n\n* Individuals with radiculopathy and ipsilateral irradiation, osteonecrosis of the femoral head, previous arthroplasty on the hip to be studied or surgical scar that could lead to changes in the anatomy of the hip, cases of high dislocation of the hip, pain exclusively in the posterior region, symptomatic ipsilateral knee osteoarthritis, intra-articular infiltration of corticosteroids or hyaluronic acid in the hip for less than six months, patients with neurological diseases, peripheral neuropathy or psychiatric diseases, use of a pacemaker or Prothrombin Activity Time (INR) \\> 3.",{"count":188,"type":21},70,[24],"This will be a prospective, single-center, double-blinded, randomized study designed to compare the efficacy of the intraarticular injection of a corticosteroid and the Conventional Radiofrequency (CRF) of the anterior sensory branches to the hip in controlling pain and improving function related to hip osteoarthritis.",[27,28],[193,194],"denervation","Radiofrequency ablation","2024-01-14",{"date":197,"type":33},"2024-01-24",{"date":199,"type":21},"2024-02-01",{"date":201,"type":21},"2027-04-30",{"name":203,"class":40},"University of Brasilia"]